
TARE and TACE for Liver Tumors
TARE and TACE in India for selected liver tumours, with CT/MRI staging, angiographic planning and liver-directed chemoembolization or Y-90 radioembolization chosen by a multidisciplinary team.
Related Conditions
Our services are FREE and by using our services your hospital bill does not increase!
About TARE and TACE for Liver Tumors
TARE and TACE in India are catheter-based liver-directed treatments used for selected primary and metastatic liver tumours when local control, tumour reduction or disease stabilisation is appropriate. TACE (transarterial chemoembolization) delivers chemotherapy into arteries feeding the tumour and then blocks those vessels, while TARE (transarterial radioembolization) delivers radioactive microspheres, usually containing yttrium-90, through the tumour’s arterial supply. They are different procedures and are selected according to tumour type, liver function, vascular anatomy and the overall oncology plan.
Before treatment, patients usually undergo a multidisciplinary liver-tumour assessment with contrast CT or MRI, liver-function tests and review of pathology and previous cancer treatment. Angiographic mapping is particularly important before TARE to define hepatic arterial anatomy and assess non-target flow; additional nuclear-medicine testing may be required as part of Y-90 planning.
TACE is commonly used in selected hepatocellular carcinoma and some other liver-dominant tumours. TARE can also be used for selected primary or metastatic liver cancers and may be considered when tumour distribution or prior treatment makes radioembolization appropriate. Risks include post-embolization symptoms, liver dysfunction, infection, vascular complications and non-target treatment injury, with additional radiation-specific precautions after TARE.
The cost of TARE or TACE in India depends on treatment type, number of sessions, embolic or radioactive materials, angiography, imaging, hospital stay and oncology follow-up.
India offers access to interventional radiologists, nuclear-medicine specialists, hepatologists and liver-oncology teams at tertiary cancer centres. Compare liver-directed treatment expertise and estimated costs. Medical Help India can connect you with a suitable healthcare partner whose team can review CT/MRI, liver function and previous treatment and advise on appropriate next steps.
What's Included
Why consider treatment in India?
Access to experienced specialists
Advanced treatment and diagnostic options
More affordable hospital care
Shorter waiting times for treatment
Help comparing hospitals, plans and costs
Support with appointments, travel and follow-up
Cost in India
USDFinal costs depend on the medical assessment, hospital, room category and clinical needs.
How it works
Share your details
Tell us about your health concerns, age and current location.
Receive a call
We call you to discuss your situation, needs and questions.
Receive a treatment plan
Get information about the most suitable treatment plan, hospital and estimated cost.
Choose your plan
Review the options and agree on your care and travel plan.
Get full support
Receive full support throughout every stage of your care journey.
Receive care in India
Receive your planned care with support throughout your stay.
Top Hospitals for TARE and TACE for Liver Tumors
View All Hospitals →Frequently Asked Questions
How much does TARE and TACE for Liver Tumors cost in India?
Cost depends on TARE versus TACE, number of treatment sessions, radioactive or embolic materials, angiography and mapping, imaging, hospital stay and oncology follow-up. Y-90 radioembolization and chemoembolization should be quoted as separate procedure pathways.
Which medical reports are useful to have ready for TARE and TACE for Liver Tumors?
Have ready: liver-tumour pathology, contrast CT or MRI, liver-function tests, staging reports and previous surgery or systemic-treatment records. For TARE, include angiographic mapping and nuclear-medicine planning results if already performed.
What is the difference between TACE and TARE?
TACE delivers chemotherapy and embolic material into arteries feeding a liver tumour, while TARE delivers radioactive microspheres, usually containing yttrium-90, through the tumour’s arterial supply.
How is a patient selected for TARE or TACE?
Selection depends on tumour type, number and distribution of lesions, liver function, vascular anatomy, previous treatment and the broader oncology plan.
Why is mapping angiography important before TARE?
It defines hepatic arterial anatomy, helps identify vessels that could carry microspheres outside the liver target and supports planning of safe Y-90 delivery.

Our services are FREE
We connect you with leading hospitals and specialists in India. You pay the hospital directly.

